Analyst Consensus
- Current Price
- 368.03 $
- Target (Low)
- 340.00 $
- Target (Mean)
- 432.83 $
- Target (High)
- 515.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 53
Recommendation Distribution
Recommendation Distribution| Strong Buy | 14 |
|---|
| Buy | 42 |
|---|
| Hold | 7 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 37.9%
- Operating Margin
- 36.1%
- Gross Margin
- 60.4%
- Return on Equity (ROE)
- 38.9%
- Return on Assets (ROA)
- 14.6%
- Revenue Growth
- 21.8%
- Earnings Growth
- 82.0%
- Debt/Equity
- 20.03
- Current Ratio
- 1.92
- Beta
- 1.24
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 3, 2026 | Needham | Buy → Buy |
| Jun 2, 2026 | HSBC | Buy → Buy |
| Jun 1, 2026 | Piper Sandler | Overweight → Overweight |
| May 29, 2026 | Truist Securities | Buy → Buy |
| May 21, 2026 | Rosenblatt | Neutral → Neutral |
| May 20, 2026 | Keybanc | Overweight → Overweight |